Da32 Life Science Tech Acquisition Corp Cl A (DALS)
Da32 Life Science Tech Acquisition Corp Cl A (DALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||
| Net Income | N/A | -314 | -43 |
| Accounts payable and accrued liabilities | N/A | N/A | 2 |
| Other Working Capital | N/A | -572 | 43 |
| Other Operating Activity | 0 | -9 | -2 |
| Operating Cash Flow | $N/A | $-895 | $0 |
| Cash Flows From Investing Activities | |||
| Purchase Of Investment | N/A | -200,000 | N/A |
| Investing Cash Flow | $N/A | $-200,000 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 200 | 200 |
| Common Stock Issued | N/A | 206,525 | 25 |
| Other Financing Activity | 0 | -3,877 | -60 |
| Financing Cash Flow | $N/A | $202,848 | $165 |
| End Cash Position | N/A | 1,953 | 165 |
| Net Cash Flow | $N/A | $1,953 | $165 |
| Free Cash Flow | |||
| Operating Cash Flow | N/A | -895 | 0 |
| Free Cash Flow | 0 | -895 | 0 |